Cargando…

End-point definition and trial design to advance tuberculosis vaccine development

Tuberculosis (TB) remains a leading infectious cause of death worldwide and the coronavirus disease 2019 pandemic has negatively impacted the global TB burden of disease indicators. If the targets of TB mortality and incidence reduction set by the international community are to be met, new more effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia-Basteiro, Alberto L., White, Richard G., Tait, Dereck, Schmidt, Alexander C., Rangaka, Molebogeng X., Quaife, Matthew, Nemes, Elisa, Mogg, Robin, Hill, Philip C., Harris, Rebecca C., Hanekom, Willem A., Frick, Mike, Fiore-Gartland, Andrew, Evans, Tom, Dagnew, Alemnew F., Churchyard, Gavin, Cobelens, Frank, Behr, Marcel A., Hatherill, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488660/ https://www.ncbi.nlm.nih.gov/pubmed/35675923 http://dx.doi.org/10.1183/16000617.0044-2022

Ejemplares similares

Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?
por: Nelson, Kristin N, et al.
Publicado: (2023)

The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials
por: Abubakar, Ibrahim, et al.
Publicado: (2020)

Evaluation of a transcriptomic signature of tuberculosis risk in combination with an interferon gamma release assay: A diagnostic test accuracy study
por: Mulenga, Humphrey, et al.
Publicado: (2022)

Clinical predictors of pulmonary tuberculosis among South African adults with HIV
por: Mendelsohn, Simon C., et al.
Publicado: (2022)

Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?
por: Rangaka, Molebogeng X, et al.
Publicado: (2022)

Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention
por: Fiore-Gartland, Andrew, et al.
Publicado: (2018)

The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis risk
por: Mulenga, Humphrey, et al.
Publicado: (2022)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
por: McShane, Helen, et al.
Publicado: (2016)

World TB Day 2018: The Challenge of Drug Resistant Tuberculosis
por: Gupta-Wright, Ankur, et al.
Publicado: (2018)

Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR
por: Mendelsohn, Simon C., et al.
Publicado: (2022)

A user-centred design framework for mHealth
por: Farao, Jaydon, et al.
Publicado: (2020)

Tuberculosis Antigen-Specific T-Cell Responses During the First 6 Months of Antiretroviral Treatment
por: Riou, Catherine, et al.
Publicado: (2020)

Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence
por: Hamada, Yohhei, et al.
Publicado: (2021)

Pneumocystis jirovecii Pneumonia in Tropical and Low and Middle Income Countries: A Systematic Review and Meta-Regression
por: Lowe, David M., et al.
Publicado: (2013)

C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study
por: Mendelson, Fiona, et al.
Publicado: (2018)

Isolation of Non-Tuberculous Mycobacteria in Children Investigated for Pulmonary Tuberculosis
por: Hatherill, Mark, et al.
Publicado: (2006)

Comparison of Mantoux and Tine Tuberculin Skin Tests in BCG-Vaccinated Children Investigated for Tuberculosis
por: Pan, Wenli, et al.
Publicado: (2009)

Targeting Unconventional Host Components for Vaccination-Induced Protection Against TB
por: Nemes, Elisa, et al.
Publicado: (2020)

The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges
por: Naidoo, Pren, et al.
Publicado: (2017)

Development of a clinical prediction rule to diagnose Pneumocystis jirovecii pneumonia in the World Health Organization’s algorithm for seriously ill HIV-infected patients
por: Maartens, Gary, et al.
Publicado: (2018)

The impact of COVID-19 on global tuberculosis control
por: Lipman, Marc, et al.
Publicado: (2021)

Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial
por: Nemes, Elisa, et al.
Publicado: (2018)

Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all?
por: Nathavitharana, Ruvandhi R., et al.
Publicado: (2022)

Correction: The Tuberculin Skin Test versus QuantiFERON TB Gold® in Predicting Tuberculosis Disease in an Adolescent Cohort Study in South Africa
por: Mahomed, Hassan, et al.
Publicado: (2011)

The Tuberculin Skin Test versus QuantiFERON TB Gold® in Predicting Tuberculosis Disease in an Adolescent Cohort Study in South Africa
por: Mahomed, Hassan, et al.
Publicado: (2011)

Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis
por: Gupta, Rishi K, et al.
Publicado: (2020)

Durable Expansion of TCR-δ Meta-Clonotypes After BCG Revaccination in Humans
por: James, Charlotte A., et al.
Publicado: (2022)

Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial
por: Hawkridge, Anthony, et al.
Publicado: (2008)

Altered Ratio of IFN-γ/IL-10 in Patients with Drug Resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome
por: Skolimowska, Keira H., et al.
Publicado: (2012)

Electrocardiographic characteristics of definite drug induced Brugada patients
por: Ensam, B, et al.
Publicado: (2023)

Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population
por: Ige, Fehintola, et al.
Publicado: (2021)

4. Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Adults
por: Dagnew, Alemnew F, et al.
Publicado: (2020)

Role of the Interleukin 10 Family of Cytokines in Patients With Immune Reconstitution Inflammatory Syndrome Associated With HIV Infection and Tuberculosis
por: Tadokera, Rebecca, et al.
Publicado: (2013)

Tracking COVID-19 using online search
por: Lampos, Vasileios, et al.
Publicado: (2021)

Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials
por: Dagnew, Alemnew F, et al.
Publicado: (2020)

Evaluation of antibiotic utilization pattern in the treatment of acute diarrheal diseases at Debre Tabor comprehensive specialized hospital, Debre Tabor, Ethiopia: A retrospective cross-sectional study
por: Addis, Getu Tesfaw, et al.
Publicado: (2023)

Development of a consensus operational definition of child assent for research
por: Tait, Alan R., et al.
Publicado: (2017)

Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview
por: Dagnew, Alemnew F., et al.
Publicado: (2021)

Drug-related problems and associated factors among adult psychiatric inpatients in Northwest Ethiopia: Multicenter cross-sectional study
por: Dagnew, Ephrem Mebratu, et al.
Publicado: (2022)

Safety and immunogenicity of candidate vaccine M72/AS01(E) in adolescents in a TB endemic setting
por: Penn-Nicholson, Adam, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_guf0mqvhqslu8aed0icru3fv4j